Study evaluates periodic aflibercept injections in NPDR treatment

The proportion of eyes that developed PDR or centre-involving DMO was lower with periodic aflibercept treatments compared with sham treatment through the 2-year point.

Addressing Drug Delivery Gaps in Retinal Disease

Following a discussion regarding drug delivery challenges in retinal disease, a panel of global experts suggest what types of technological requirements and improvements they would like to see occur in the field.

Drug Delivery Challenges in Retinal Disease

Challenges associated with delivering therapies currently available to treat retinal disorders and methods being explored to improve drug delivery to patients.